Diabetes may impair myocardial proangiogenic response

January 10, 2017

(HealthDay)—The amplitude of therapeutic revascularization associated with recombinant adeno-associated virus (rAAV) (5 × 1012 viral particles encoding thymosin beta 4 [Tβ4]) is reduced with diabetes mellitus, according to an experimental study published in the Jan. 17 issue of the Journal of the American College of Cardiology.

Rabea Hinkel, D.V.M., from the Technical University of Munich, and colleagues obtained myocardial samples from patients with end-stage heart failure, and used diabetic (db) and wild-type (wt) pigs to analyze myocardial vascularization and function. The authors introduced chronic ischemia percutaneously in the circumflex artery on day 0. At day 28, they applied rAAV (5 × 1012 encoding vascular endothelial growth factor-A or rAAV.Tβ4) regionally.

The researchers found that, compared with nondiabetic explants, diabetic human myocardial explants revealed capillary rarefaction and pericyte loss. In db pigs, hyperglycemia induced capillary rarefaction in the myocardium, even without ischemia, concomitant with a distinct loss of ejection fraction (EF). In chronic ischemic hearts, density further decreased, as did EF. Capillary density and maturity were enhanced in db hearts less efficiently than in wt hearts following treatment with rAAV.Tβ4, similar to collateral growth. rAAV.Tβ4 improved EF in db hearts, but to a lesser extent than in wt .

"Diabetes mellitus destabilized microvascular vessels of the heart, affecting the amplitude of therapeutic neovascularization via rAAV.Tβ4 in a translational large animal model of hibernating myocardium," the authors write.

One author filed and licensed patent applications on microRNA biomarkers.

Explore further: Persistent gene therapy in muscle may not require immunosuppression

More information: Full Text
Editorial

Related Stories

Persistent gene therapy in muscle may not require immunosuppression

November 15, 2013
Successful gene therapy is based on the effective delivery and maintained expression of healthy copies of a gene into tissues of individuals with a disease-associated genetic mutation. Recombinant adeno-associated virus (rAAV) ...

Newly identified host defense mechanism protects cells from viral infection

April 20, 2016
A new study to understand why viral particles tend to accumulate in a specific location around a cell's nucleus in the first several hours after viral infection has shown this phenomenon to be a novel defense mechanism used ...

Mouse model could help identify viral vectors that may cause tumors

October 26, 2012
Investigators at Nationwide Children's Hospital have identified a mouse model that could help evaluate the risk that viral vectors used in gene therapy might promote tumor formation as a side-effect. The study appears in ...

Profound hypothermia best avoided in initial reperfusion

January 21, 2016
(HealthDay)—For hearts donated after circulatory death (DCD), avoidance of profound hypothermia during initial reperfusion (IR) improves functional recovery, according to a study published online Jan. 18 in the American ...

Statin rx may prevent myocardial ischemia-reperfusion injury

September 12, 2016
(HealthDay)—Postconditioning with rosuvastatin prevents myocardial ischemia-reperfusion injury in a rat model, according to a study published online Aug. 31 in Cardiovascular Therapeutics.

Macrophage-dependent IL-1beta production induces cardiac arrhythmias in diabetic mice

November 24, 2016
One of the most serious complications of diabetes, heart arrhythmias, is now on its way to be prevented and combated. Researchers from the Federal University of Rio de Janeiro (UFRJ) in partnership with investigators from ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.